InvestorsHub Logo
Followers 28
Posts 6019
Boards Moderated 0
Alias Born 10/30/2013

Re: None

Sunday, 08/07/2022 7:48:04 PM

Sunday, August 07, 2022 7:48:04 PM

Post# of 27643
DESCRIPTION
Recombinant Major pollen allergen Bet v 1-A produced in SF9 is a glycosylated, polypeptide chain having a calculated molecular mass of 18,942 Dalton.
Bet v 1.0101 is expressed with a 10xHis tag at N-terminus and purified by proprietary chromatographic techniques.

SOURCE
Sf9 insect cells.
Major pollen allergen Bet v 1-A Recombinant, Sf9
https://www.prospecbio.com/bet_v_10101

Study investigates the production of a virosome-based COVID-19 vaccine candidate
For all N-linked glycan sites already identified in current literature, purified S protein was analyzed using liquid chromatography-mass spectrometry (LC-MS) to determine site-specific glycosylation and glycan composition. At glycosylation sites N 68_81, N172, N241, and N1081, a combination of high mannose and complex/paucimannose-type glycans were discovered; the remaining 15 sites were dominated by processed, complex-type glycans.
https://www.news-medical.net/news/20220418/Study-investigates-the-production-of-a-virosome-based-COVID-19-vaccine-candidate.aspx
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMX News